Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum immunoglobulin E in primary IgA nephropathy

K H Shu1, Y S Lu, C H Chen

  • 1Department of Internal Medicine, Taichung Veterans General Hospital, Taiwan, Republic of China.

Clinical Nephrology
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-beat estimation of end-systolic pressure-volume relation in humans. A new method with the potential for noninvasive application.

Circulation·1996
Same author

A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function.

The Journal of biological chemistry·1996
Same author

Lack of association between TaqI A1 allele of dopamine D2 receptor gene and alcohol-use disorders in atayal natives of Taiwan.

American journal of medical genetics·1996
Same author

Apoptosis induced by X-irradiation of rec-myc cells is postmitotic and not predicted by the time after irradiation or behavior of sister cells.

Cancer research·1996
Same author

Thermodynamic and fluorescence studies of the underlying factors in benzyl alcohol-induced lipid interdigitated phase.

Archives of biochemistry and biophysics·1996
Same author

Expression of an avian CD6 candidate is restricted to alpha beta T cells, splenic CD8+ gamma delta T cells and embryonic natural killer cells.

European journal of immunology·1996
Same journal

Rituximab improves the control of pediatric nephrotic syndrome and reduces healthcare utilization.

Clinical nephrology·2026
Same journal

Telitacicept combined with glucocorticoids in adult-onset IgA vasculitis nephritis: A case report.

Clinical nephrology·2026
Same journal

Systematic review of risk prediction models for autogenous arteriovenous fistula dysfunction in maintenance hemodialysis patients.

Clinical nephrology·2026
Same journal

Composite dietary antioxidant index in predicting chronic kidney disease risk: Findings from NHANES 1999 - 2018.

Clinical nephrology·2026
Same journal

Clinical characteristics and outcomes of adults with minimal change disease: A retrospective, cross-sectional study.

Clinical nephrology·2026
Same journal

Analysis of end-stage renal disease mediated by cuproptosis-related genes.

Clinical nephrology·2026
See all related articles

Elevated serum immunoglobulin E (sIgE) levels are significantly higher in primary IgA nephropathy (IgA N) patients, particularly those with early-stage disease or stable nephrotic proteinuria. This finding suggests sIgE may be a useful biomarker in IgA N management.

Area of Science:

  • Immunology
  • Nephrology
  • Biochemistry

Background:

  • Immunoglobulin E (IgE) biosynthesis is complex, involving T and B lymphocytes.
  • High serum IgE (sIgE) is linked to T cell disorders and is clinically relevant in minimal change nephrotic syndrome.
  • The role of sIgE in primary IgA nephropathy (IgA N) remains understudied.

Purpose of the Study:

  • To investigate the clinical significance of serum IgE levels in patients with primary IgA nephropathy.
  • To compare sIgE levels in IgA N patients with healthy controls and analyze correlations with disease severity and proteinuria status.

Main Methods:

  • Retrospective study of 99 primary IgA N patients.
  • Serum IgE levels measured and compared to healthy controls.
  • IgA N cases stratified by pathological grade and proteinuria status (stable vs. progressive).

Related Experiment Videos

Main Results:

  • Median sIgE in IgA N patients (122.0 IU/ml) was significantly higher than controls (43.7 IU/ml).
  • Grades I and II IgA N showed significantly elevated sIgE compared to controls.
  • Patients with stable nephrotic proteinuria had higher sIgE (922.0 IU/ml) than progressive cases (55.3 IU/ml).

Conclusions:

  • Serum IgE levels are significantly elevated in primary IgA nephropathy, especially in earlier stages.
  • Higher sIgE levels in stable nephrotic proteinuria suggest a potential role as a biomarker.
  • Further research is warranted to explore the therapeutic implications of sIgE in IgA N.